Edition:
India

Ligand Announces Amgen’S Kyprolis Approved By FDA To Treat Multiple Myeloma


Monday, 24 Aug 2020 

Aug 24 (Reuters) - Ligand Pharmaceuticals Inc ::LIGAND ANNOUNCES AMGEN’S KYPROLIS® APPROVED BY FDA AS COMBINATION REGIMEN WITH DARZALEX® AND DEXAMETHASONE IN ONCE- AND TWICE-WEEKLY DOSING REGIMENS FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA.LIGAND PHARMACEUTICALS - AMGEN HAS SUBMITTED ADDITIONAL MARKETING APPLICATIONS GLOBALLY FOR KYPROLIS.